Company Profile
Alchemab Therapeutics Ltd
12156844•Private Limited With Share Capital
Get Full Access
14/08/2019
6 years
5
60
72110
high risk
Company Overview
Registration, classification & business activity
Alchemab Therapeutics Ltd (12156844) is a private limited with share capital incorporated on 14/08/2019 (6 years old) and registered in london, N1C4AX. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development. alchemab takes an unbiased and function-first approach using three complementary processes and cutting-e...
Financial Overview
£22.43M
£31.77M
£-9.34M
£1.59M
£15.58M
Key Metrics
60
Employees
5
Directors
53
Shareholders
25
Patents
Board of Directors
Charges
1
Registered
0
Outstanding
0
Part Satisfied
1
Satisfied
Innovate Grants
This company received a grant of £988266.0 for Novel Protective 'Self'-Antibodies For Disease Modification In Huntington’S Disease. The project started on 01/03/2021 and ended on 31/10/2022.
This company received a grant of £1350188.0 for Pre-Clinical Development Of Novel ‘Self’-Antibodies For Disease Modification In Huntington’S Disease. The project started on 01/12/2022 and ended on 28/02/2025.
Import / Export
Risk Assessment
high risk
International Score
Future Factor
emerging
Performance Rating